Independent prognostic value of serum hepatocyte growth factor in bladder cancer

Journal of Clinical Oncology

Volumn 18, Issue 16, 2000, Pages 2963-2971

  Gohji, Kazuo ^a   Nomi, Masashi ^a   Niitani, Yoshiyuki ^a   Kitazawa, Sohei ^a   Fujii, Akio ^a   Katsuoka, Yoji ^a   Nakajima, Motowo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD LEVEL; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TISSUE LEVEL; TRANSITIONAL CELL CARCINOMA;

EID: 0033872296     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.16.2963     Document Type: Article

References (26)

1. Cancer statistics, 1995
2. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder
3. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
4. Use of a new tumor marker urinary NMP 22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
5. Prognostic significance of circulating matrix mertalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection
6. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor
7. Scatter factor is a fibroblast-derived modulator of epithelial cell motility
8. Scatter factor induces blood vessel formation in vivo
9. The met proto-oncogene receptor and lumen formation
10. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
11. Expression of scatter factor in human bladder carcinoma
12. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder
13. Regression models and life-tables
14. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture
15. Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibro-blasts
16. Organ-sitedependence for the prodoction of urokinase-type plasminogen activator and metastasis by human-renal cell carcinoma cells
17. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer
18. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
19. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients
20. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma
21. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
22. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
23. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator
24. The content of urokinase-type plasaminogen activator ahtigen as a prognostic factor in urinary bladder cancer
25. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro
26. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma